The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies
Matthew J Sheetz, Lloyd Paul Aiello, Matthew D Davis, Ronald Danis, Toke Bek, Jose Cunha-Vaz, Nazila Shahri, Paul H Berg, MBDL and MBCU Study Groups
61
Citationer
(Scopus)